PharmaEngine
PharmaEngine
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of PEP08 in Patients With MTAP-Del Advanced or Metastatic Solid Tumors | Advanced Solid Tumor; MTAP Deletion; MTAP-deleted Solid Tumors; Solid Tumors | Recruiting | Phase 1 | 2026-02-13 | NCT06973863 | |
| A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2025-07-31 | NCT05659732 | |
| A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients with Advanced or Metastatic Solid Tumors | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 1 | 2024-11-07 | NCT05983523 |